September 7, 2021
“Wall Street’s favorites among the S&P 500 Analysts who work for brokerage firms tend to shy away from negative ratings. Among the S&P 500, there are no companies with majority “sell” or equivalent ratings. But the analysts still have clear… Continue Reading…
August 31, 2021
“…Robinhood shares closed 6.9% lower after Barron’s published an interview with SEC Chairman Gary Gensler in which he said a full prohibition of payment for order flow was “on the table” as part of a broader agency review. Robinhood’s stock was briefly… Continue Reading…
August 31, 2021
“Support.com (SPRT) erupted out of nowhere this month and is suddenly stealing the Reddit-crowd’s affection. And for good reason: It’s fast pushing GameStop aside. Shares of Support.com are up 1,583% just this year. That puts it ahead of the still-impressive 1,041%… Continue Reading…
August 27, 2021
“EDITOR NOTE: Citigroup is the latest financial institution to warn investors about significant losses in the stock market in the near future. “Our panic/euphoria model remains very elevated and is warning of coming losses,” the bank’s analysts say. These experts… Continue Reading…
August 25, 2021
“Enovix (ENVX)… Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the message is clear: ENVX is a Strong Buy. Given the $29.67 average price target, shares… Continue Reading…
August 24, 2021
“Zimmer Biomet Holdings (ZBH)… Matson’s view on ZBH is hardly an outlier, as the stock has no fewer than 13 positive reviews set in recent weeks – for a Strong Buy analyst consensus. The shares have an average price target of… Continue Reading…
August 24, 2021
“Magellan Midstream Partners (MMP)… With 9 recent reviews, including 4 Buys and 5 Holds, MMP has a Moderate Buy rating from the analyst consensus. The stock sells for $47.77, while the $52.11 average price target indicates room for ~10% upside… Continue Reading…
August 9, 2021
“Shares of Bluebird Bio Inc. were down 21.6% in premarket trading on Monday after the company announced several setbacks to its business as part of its second-quarter earnings announcement. Bluebird plans to wind down its gene therapy operations in Europe,… Continue Reading…
August 5, 2021
“EverCommerce (EVCM)… This newly public stock has picked up 13 reviews in its short time on the markets, including 11 Buys and 2 Holds for a Strong Buy consensus rating. EverCommerce shares are selling for $18.06, and their $22.15 average price… Continue Reading…
Recent Comments